The health-economic burden of hip and knee periprosthetic joint infections in Europe : a comprehensive analysis following primary arthroplasty.

IF 2.8 Q1 ORTHOPEDICS
Volker Alt, Dominik Szymski, Markus Rupp, Andreas Fontalis, Danguole Vaznaisiene, Leonard C Marais, Christof Wagner, Nike Walter, Volker Alt, Martin Clauss, Matteo Carlo Ferrari, Efthymia Giannitsioti, Mathias Glehr, André Grenho, Tomislav Madjarevic, Dirk J Moojen, Kaisa Huotari, Bedri Karaismailoglu, Rik Osinga, Jeroen Neyt, Imre Sallai, Andrea Sambri, Pablo Sanz-Ruiz, Ricardo Sousa, Anna Stefansdottir, Rihard Trebse, Danguole Vaznaisiene, Marianne Westberg, Christof Wagner
{"title":"The health-economic burden of hip and knee periprosthetic joint infections in Europe : a comprehensive analysis following primary arthroplasty.","authors":"Volker Alt, Dominik Szymski, Markus Rupp, Andreas Fontalis, Danguole Vaznaisiene, Leonard C Marais, Christof Wagner, Nike Walter, Volker Alt, Martin Clauss, Matteo Carlo Ferrari, Efthymia Giannitsioti, Mathias Glehr, André Grenho, Tomislav Madjarevic, Dirk J Moojen, Kaisa Huotari, Bedri Karaismailoglu, Rik Osinga, Jeroen Neyt, Imre Sallai, Andrea Sambri, Pablo Sanz-Ruiz, Ricardo Sousa, Anna Stefansdottir, Rihard Trebse, Danguole Vaznaisiene, Marianne Westberg, Christof Wagner","doi":"10.1302/2633-1462.63.BJO-2024-0225.R1","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Periprosthetic joint infections (PJIs) pose significant challenges to patients and healthcare systems worldwide. The aim of this study was to estimate the health-economic burden of reimbursement payment in Europe for PJIs following primary hip and knee arthroplasty.</p><p><strong>Methods: </strong>The calculation was based on health-economic modelling using data on primary hip and knee arthroplasties for the year 2019 from the Statistical Office of the European Union (Eurostat) and published infection rates to estimate the total number of hip and knee PJIs in 30 European countries. Revision procedures were stratified into: 1) debridement, antibiotics, and implant retention (DAIR); 2) one-stage exchange; and 3) two-stage revision procedures. The cases were then multiplied by the respective healthcare system reimbursement payments. Payment data were acquired from a survey of 13 countries (Austria, Croatia, France, Germany, Italy, Lithuania, Netherlands, Norway, Portugal, Slovenia, Switzerland, Turkey, and the UK) and extrapolated for the remaining countries.</p><p><strong>Results: </strong>In 2019, a total of 2,048,778 primary total joint replacements were performed (total hip arthroplasty (THA) = 1,147,316 and total knee arthroplasty (TKA) = 901,462), with an estimated 20,416 cases of PJIs (11,131 hip and 9,285 knee) in Europe. This results in an estimated total reimbursement burden of €346,262,026 for European healthcare systems. The breakdown for hip PJI reimbursement was €197,230,953 (€9,751,962 for DAIR procedures, €45,135,894 for one-stage revisions, and €142,343,097 for two-stage revisions). For knee PJIs, the analysis yielded a total reimbursement of €149,031,073 (€9,335,075 for DAIR procedures, €48,058,479 for one-stage revisions, and €91,637,518 for two-stage revisions).</p><p><strong>Conclusion: </strong>This is the first study to evaluate the health-economic burden of PJIs in Europe, revealing a substantial impact on healthcare systems with an estimated case load of 20,414 cases and overall reimbursement of €346,262,026 for primary THAs and TKAs performed in 2019.</p>","PeriodicalId":34103,"journal":{"name":"Bone & Joint Open","volume":"6 3","pages":"298-311"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11888791/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone & Joint Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1302/2633-1462.63.BJO-2024-0225.R1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: Periprosthetic joint infections (PJIs) pose significant challenges to patients and healthcare systems worldwide. The aim of this study was to estimate the health-economic burden of reimbursement payment in Europe for PJIs following primary hip and knee arthroplasty.

Methods: The calculation was based on health-economic modelling using data on primary hip and knee arthroplasties for the year 2019 from the Statistical Office of the European Union (Eurostat) and published infection rates to estimate the total number of hip and knee PJIs in 30 European countries. Revision procedures were stratified into: 1) debridement, antibiotics, and implant retention (DAIR); 2) one-stage exchange; and 3) two-stage revision procedures. The cases were then multiplied by the respective healthcare system reimbursement payments. Payment data were acquired from a survey of 13 countries (Austria, Croatia, France, Germany, Italy, Lithuania, Netherlands, Norway, Portugal, Slovenia, Switzerland, Turkey, and the UK) and extrapolated for the remaining countries.

Results: In 2019, a total of 2,048,778 primary total joint replacements were performed (total hip arthroplasty (THA) = 1,147,316 and total knee arthroplasty (TKA) = 901,462), with an estimated 20,416 cases of PJIs (11,131 hip and 9,285 knee) in Europe. This results in an estimated total reimbursement burden of €346,262,026 for European healthcare systems. The breakdown for hip PJI reimbursement was €197,230,953 (€9,751,962 for DAIR procedures, €45,135,894 for one-stage revisions, and €142,343,097 for two-stage revisions). For knee PJIs, the analysis yielded a total reimbursement of €149,031,073 (€9,335,075 for DAIR procedures, €48,058,479 for one-stage revisions, and €91,637,518 for two-stage revisions).

Conclusion: This is the first study to evaluate the health-economic burden of PJIs in Europe, revealing a substantial impact on healthcare systems with an estimated case load of 20,414 cases and overall reimbursement of €346,262,026 for primary THAs and TKAs performed in 2019.

欧洲髋关节和膝关节假体周围关节感染的健康经济负担:原发性关节置换术后的综合分析。
目的:假体周围关节感染(PJIs)对全世界的患者和医疗保健系统构成了重大挑战。本研究的目的是估计欧洲原发性髋关节和膝关节置换术后PJIs报销支付的健康经济负担。方法:该计算基于健康经济模型,使用欧盟统计局(Eurostat) 2019年原发性髋关节和膝关节置换术的数据和公布的感染率,以估计30个欧洲国家髋关节和膝关节pji的总数。翻修程序分为:1)清创、抗生素和种植体保留(DAIR);2)一级交换;3)两阶段修订程序。然后将病例乘以各自的医疗保健系统报销付款。支付数据来自对13个国家(奥地利、克罗地亚、法国、德国、意大利、立陶宛、荷兰、挪威、葡萄牙、斯洛文尼亚、瑞士、土耳其和英国)的调查,并对其余国家进行了推断。结果:2019年,欧洲共进行了2,048,778例原发性全关节置换术(全髋关节置换术(THA) = 1,147,316例,全膝关节置换术(TKA) = 901,462例),估计有20,416例PJIs(11,131例髋关节和9,285例膝关节)。这导致欧洲医疗保健系统的总偿还负担估计为346,262,026欧元。髋部PJI报销分项为197,230,953欧元(DAIR程序为9,751,962欧元,一阶段修订为45,135,894欧元,两阶段修订为142,343,097欧元)。对于膝关节pji,分析得出的总报销额为149,031,073欧元(DAIR程序为9,335,075欧元,一阶段修订为48,058,479欧元,两阶段修订为91,637,518欧元)。结论:这是第一项评估欧洲pji健康经济负担的研究,揭示了对医疗保健系统的重大影响,估计病例负荷为20,414例,2019年进行的初级THAs和tka的总报销额为346,262,026欧元。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bone & Joint Open
Bone & Joint Open ORTHOPEDICS-
CiteScore
5.10
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信